Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid

European Journal of Nuclear Medicine

Volumn 23, Issue 10, 1996, Pages 1367-1371

  Uǧur, Ömer ^a   Kostakoǧlu, Lale ^a   Güler, Nilüfer ^a   Caner, Biray ^a   Uysal, Uǧur ^a   Elahi, Nazenin ^a   Haliloǧlu, Mithat ^a   Yüksel, Doǧangün ^b   Aras, Tülin ^a   Bayhan, Hikmet ^b   Bekdik, Coşkun ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Medullary thyroid carcinoma; Technetium 99m (pentavalent) DMSA; Technetium 99m sestamibi; Thallium 201; Tumour imaging

Indexed keywords

CALCITONIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SUCCIMER TC 99M; THALLIUM 201; DIAGNOSTIC AGENT; SUCCIMER; TECHNETIUM COMPLEX; THALLIUM;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CALCITONIN BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGING; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; SCINTISCANNING; SOFT TISSUE TUMOR; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; BLOOD; BONE TUMOR; COMPARATIVE STUDY; MEDULLARY CARCINOMA; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; THYROID TUMOR; TUMOR RECURRENCE;

ADULT; AGED; BONE NEOPLASMS; CALCITONIN; CARCINOMA, MEDULLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOTECHNETIUM COMPOUNDS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; SUCCIMER; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; THYROID NEOPLASMS;

EID: 0029665302     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01367593     Document Type: Article

References (14)

1. Brunt LM, Wells SA. Advances in the diagnosis and treatment of medullary thyroid carcinoma. Surg Clin North Am 1987; 67: 263-279.
2. Sisson JC, Ackermann R, Meyer MA, Wahl RL. Uptake of FDG by thyroid cancer: implications for diagnosis and therapy. J Clin Endocrinol Metab 1993; 77: 1090-1094.
3. Ohta H, Yamamato K, Endo K, Mori T, Hamanaka D, Shimazu A, Ikekubo K, Makimoto K, Lida Y, Konishi J, Morita R, Hata N, Horiuchi K, Yokoyama A, Torizuka K, Kuma K. A new imaging agent for medullary carcinoma of the thyroid. J Nucl Med 1984; 25: 323-325.
4. 99mTc] MDP - an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med 1988; 29: 33-38.
5. Clarke SEM. Medullary thyroid cancer. In: Murray IPC, Ell PC, Strauss HW, eds. Nuclear medicine in clinical diagnosis and treatment. New York: Churchill Livingstone; 1994; 677-685.
6. Arnstein NB, Juni JE, Sisson JC, Lloyd RV, Thompson NW. Recurrent medullary thyroid carcinoma of the thyroid demonstrated by thallium-201 scintigraphy. J Nucl Med 1986; 27: 1564-1568.
7. O'Driscoll CM, Baker F, Casey MJ, Duffy GJ. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report. J Nucl Med 1991; 32: 2281-2283.
8. Lebouthillier G, Morais J, Picard M, Picard D, Chartrand R, D'amour P. Tc-99m-sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid. Clin Nucl Med 1993; 18: 657-661.
9. Frohman LA. Endocrine manifestations of neoplasia. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison's principles of internal medicine, 11th edn. New York: McGraw-Hill; 1987: 1597-1600.
10. Wahl RL. Positron emission tomography: applications in oncology. In: Murray IPC, Ell PJ, Strauss HW, eds. Nuclear medicine in clinical diagnosis and treatment. New York: Churchill Livingstone; 1994: 801-820.
11. 18F] fluorodeoxyglucose (PET-FDG): an indispensable tool in proper management of brain tumors. In: Hubner KF, Collmann J, Buonocore E, Kabalka GW, eds. Clinical positron emission tomography. St. Louis: Mosby-Year Book; 1992: 50-60.
12. Waxman AD. Thallium-201 in nuclear oncology. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press; 1991: 193-209.
13. 99mTc sestamibi in tumor imaging. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press; 1994: 181-234.
14. Uǧur Ö, Kostakoǧlu L, Caner B, Güler N, Gülaldi NCM, Özmen M, Uysal U, Elahi N, Erbengi G, Bekdik C. Comparison of Tl-201, Tc-99m-MIBI and I-131 imaging in the follow-up of patients with well differentiated thyroid carcinoma. Nucl Med Commun 1996; 17: 373-377.